Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung? Source: Eur Respir J 2001; 18: Suppl. 33, 179s Year: 2001
Exhaled nitric oxide after lung transplantation: impact of the native lung Source: Eur Respir J 2003; 21: 429-432 Year: 2003
Infections increase exhaled nitric oxide, but not carbon monoxide levels in lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 329s Year: 2003
Extended measurement of exhaled nitric oxide in patients after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 705s Year: 2005
Diagnostic use of exhaled nitric oxide (eNO) after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006
The effect of switching cyclosporin A (CyA) to tacrolimus (FK) on exhaled nitric oxide (eNO) and pulmonary function in patients with chronic rejection after lung transplantation (LTx) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002
Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002
Sputum neutrophilia is correlated with levels of exhaled nitric oxide (NO) in patients with chronic, stable sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 344s Year: 2001
Exhaled nitric oxide measured at different flow rates to detect early bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019
Pulmonary function test and fraction of exhaled nitric oxide of asthma in remission Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017
A 2-year follow-up of exhaled nitric oxide (FeNO) and pulmonary function tests in young patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001
Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy. Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Exercise training and exhaled nitric oxide (eNO) in COPD patients of different severity Source: Eur Respir J 2001; 18: Suppl. 33, 222s Year: 2001
Effects of posttransplant bronchiolitis obliterans syndrome (BOS) on exhaled nitric oxide (eNO) Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment Year: 2003
Reference values of fractional exhaled nitric oxide in stable lung transplant recipients – a prospective study Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009
Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009